These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22397557)

  • 1. Host genetics and invasive fungal diseases: towards improved diagnosis and therapy?
    Cunha C; Carvalho A
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):257-9. PubMed ID: 22397557
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnosis of fungal infection in immunocompromised patients.
    Barnes RA
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i3-6. PubMed ID: 18063601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive mycoses: evolving challenges and opportunities in antifungal therapy. Introduction.
    Perfect JR
    Am J Med; 2012 Jan; 125(1 Suppl):S1-2. PubMed ID: 22196204
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of invasive fungal diseases in neutropenic patients.
    Almyroudis NG; Segal BH
    Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic profiling to predict risk of invasive fungal diseases: where are we now?
    Cunha C; Aversa F; Bistoni G; Casagrande A; Rodrigues F; Romani L; Carvalho A
    Immunol Invest; 2011; 40(7-8):723-34. PubMed ID: 21985302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity).
    Perfect JR; Pfaller MA; Ostrosky-Zeichner L; Kontoyiannis DP
    Am J Med; 2011 Oct; 124(10):S2-3. PubMed ID: 21962326
    [No Abstract]   [Full Text] [Related]  

  • 7. When primary antifungal therapy fails.
    Nucci M; Perfect JR
    Clin Infect Dis; 2008 May; 46(9):1426-33. PubMed ID: 18419447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards molecular diagnostics of invasive fungal infections.
    Preuner S; Lion T
    Expert Rev Mol Diagn; 2009 Jul; 9(5):397-401. PubMed ID: 19580423
    [No Abstract]   [Full Text] [Related]  

  • 9. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of fungal infections in immunocompromised patients.
    Venkatesan P; Perfect JR; Myers SA
    Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocompromised hosts: immunopharmacology of modern antifungals.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2008 Jul; 47(2):226-35. PubMed ID: 18540822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of fungal infections in pediatrics].
    Hernández-Sampelayo T; Navarro Gómez ML; Hernández Molina JM; Gómez Campderá JA
    Rev Clin Esp; 1997 Apr; 197 Suppl 1():60-6. PubMed ID: 9297208
    [No Abstract]   [Full Text] [Related]  

  • 13. Empirical antifungal treatment: a valid alternative for invasive fungal infection.
    Vallejo C; Barberán J
    Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the host on fungal infections.
    Perfect JR
    Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of immunocompromised patients with evidence of an invasive mycosis.
    Walsh TJ
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zygomycetes and Pythium spp., an aquatic phycomycetes isolated from patients and their host defense mechanism.
    Tanphaichitra D; Srimuang S; Siristonpun Y
    J Chemother; 1989 Jul; 1(4 Suppl):931-3. PubMed ID: 16312710
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy for fungal diseases: opportunities and priorities.
    Denning DW; Hope WW
    Trends Microbiol; 2010 May; 18(5):195-204. PubMed ID: 20207544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy?
    de Pauw BE; Donnelly JP
    Clin Infect Dis; 2009 Apr; 48(8):1052-4. PubMed ID: 19281329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.